# Saya Bio

> Saya Bio is a VC fund in California City backing Health Care and Biotechnology. See 17 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: California City, United States
- Total investments: 17
- Last investment: Sep 2024
- Lead investor: 6%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/saya-bio/
- Website: https://saya.bio/

Saya Bio is a VC fund in California City focused on Health Care and Biotechnology. We are a specialized investment fund in biotechnology that also functions as a company builder. Our mission is to create and support innovative companies, guiding them from inception to commercial launch. As a dynamic company builder, we provide support to emerging companies in agrowth-focused and innovative environment. We deliver comprehensiveservices in finance, accounting, legal, compliance, and recruitment to help startups thrive and succeed.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 8 | 47% |
| Biotechnology | 8 | 47% |
| Medical | 4 | 24% |
| Therapeutics | 4 | 24% |
| Software | 3 | 18% |

26 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 35% |
| Series A | 3 | 18% |
| Pre-Seed | 2 | 12% |
| Series B | 2 | 12% |
| Series D | 2 | 12% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 10 | 59% |
| Mexico | 2 | 12% |
| Germany | 1 | 6% |
| United Kingdom | 1 | 6% |
| The Netherlands | 1 | 6% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Macloud | Macloud empowers farmers to boost efficiency and profitability through a one-stop digital platform offering seamless access to agricultural inputs, equipment, financial services, and cutting-edge agtech solutions tailored to their needs.Macloud successfully secured its initial seed funding, led by Grupo Tracsa's family office tech fund. Thisstrategic investment provides Macloud with access to a robust product portfolio, an extensive B2B network, and significant cross-selling opportunities within an established, loyal customer base. | $2M | Seed | Sep 01, 2024 |  |
| Macloud | Macloud empowers farmers to boost efficiency and profitability through a one-stop digital platform offering seamless access to agricultural inputs, equipment, financial services, and cutting-edge agtech solutions tailored to their needs.Macloud successfully secured its initial seed funding, led by Grupo Tracsa's family office tech fund. Thisstrategic investment provides Macloud with access to a robust product portfolio, an extensive B2B network, and significant cross-selling opportunities within an established, loyal customer base. |  | Pre-Seed | Jan 01, 2023 |  |
| Infinimmune | Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system. | $12M | Seed | Dec 06, 2022 |  |
| CHARM Therapeutics | CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins. | $50M | Series A | Jun 09, 2022 |  |
| Levels | Levels develops a health and wellness platform designed to monitor metabolic fitness. The platform tracks blood glucose in real-time, enabling users to optimize their diet and exercise. The company was founded in 2019 and is a remote-first company. | $38M | Series A | Apr 20, 2022 |  |
| Nophin | Commercial real estate managers can use Nophin's AI copilot to underwrite deals, automate manual data entry, and generate worksheet analysis. Previously, Nophin offered credit and banking software for SMB landlords. |  | Pre-Seed | Apr 04, 2022 |  |
| Nophin | Commercial real estate managers can use Nophin's AI copilot to underwrite deals, automate manual data entry, and generate worksheet analysis. Previously, Nophin offered credit and banking software for SMB landlords. | $2M | Seed | Apr 04, 2022 |  |
| Finless Foods | Plant-based and cell-cultured seafood that changes how the world eats… and supports healthy oceans.OUR MISSION IS SIMPLE – we want to create a future where the ocean thrives. We work toward this every day by creating delicious, alternative seafood products that help you satisfy your cravings from the sea without bait or a hook. We are usingground-breaking (or rather ocean-breaking) plant and cell culture technology to revolutionize the way the world sources delicious food. Good for us. Good for the ocean. | $34M | Series B | Mar 07, 2022 |  |
| Aperiam Bio | Aperiam Bio partners with enzyme engineers and distributors to create and share stabilized, solubilized, and catalytically optimized proteins. The company was founded in 2021 and is headquartered in Austin, Texas, United States. | $3.7M | Seed | Mar 07, 2022 |  |
| HelixNano | Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses. | $10M | Convertible Note | Feb 22, 2022 |  |

10 of 17 investments shown.

## Co-investors
- [F-Prime](https://shizune.co/investors/profile/f-prime-capital-partners) — VC Fund, 3 deals together
- [Presight Capital](https://shizune.co/investors/profile/presight-capital) — VC Fund, 3 deals together
- [Axial VC](https://shizune.co/investors/profile/axial-vc) — VC Fund, 2 deals together
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 2 deals together
- [Goodwater Capital](https://shizune.co/investors/profile/goodwater-capital) — VC Fund, 2 deals together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Saya Bio invest in?

Saya Bio invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Saya Bio last invest?

The most recent investment recorded for Saya Bio closed in Sep 2024. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co